Currently, there are 272.32M common shares owned by the public and among those 195.79M shares have been available to trade.
The company’s stock has a 5-day price change of -10.42% and 112.63% over the past three months. PL shares are trading 63.56% year to date (YTD), with the 12-month market performance up to 57.20% higher. It has a 12-month low price of $1.67 and touched a high of $4.99 over the same period. PL has an average intraday trading volume of 3.12 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 13.88%, 44.75%, and 77.55% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Planet Labs PBC (NYSE: PL) shares accounts for 28.95% of the company’s 272.32M shares outstanding.
It has a market capitalization of $1.21B and a beta (3y monthly) value of 1.34. The earnings-per-share (ttm) stands at -$0.47. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.57% over the week and 8.99% over the month.
Earnings per share for the fiscal year are expected to increase by 10.11%, and 43.79% over the next financial year. EPS should shrink at an annualized rate of 25.00% over the next five years, compared to 35.30% over the past 5-year period.
Looking at the support for the PL, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on September 06, 2024, with the firm’s price target at $7-$5. JMP Securities was of a view on May 02, 2023 that the stock is Mkt Outperform, while Citigroup gave the stock Buy rating on April 18, 2023, issuing a price target of $6. Morgan Stanley on their part issued Equal-Weight rating on January 23, 2023.
